Pharmaceutical industry support provided by Abbott Laboratories, Abbott Park, IL.
Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)†
Version of Record online: 12 JAN 2012
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 18, Issue 11, pages 2043–2055, November 2012
How to Cite
Sussman, D. A., Kubiliun, N., Mulani, P. M., Chao, J., Gillis, C. A.T., Yang, M., Lu, M. and T. Abreu, M. (2012), Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS). Inflamm Bowel Dis, 18: 2043–2055. doi: 10.1002/ibd.22873
- Issue online: 15 OCT 2012
- Version of Record online: 12 JAN 2012
- Manuscript Accepted: 12 DEC 2011
- Manuscript Received: 23 NOV 2011
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.